Edgar Gonzales-Escalante
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Edgar Gonzales-Escalante has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Arturo Octavio Gonzales-Rodriguez
Facultad de Medicina Humana, Universidad de Piura, Lima, Perú
4 shared publications - Juan Carlos Gómez de la Torre
Facultad de Medicina Humana, Universidad de Piura
4 shared publications - Luis Alvarado
Laboratorios Roe, lima, Peru
3 shared publications - Carlos Raúl Sevilla-Andrade
National University of San Marcos
2 shared publications Jesús H. Tamariz
Facultad de Medicina, Universidad Peruana Cayetano Heredia. Lima, Perú. Biólogo. Magíster en Microbiología. Candidato a Doctor en Ciencias
2 shared publications- Julia Piscoya Sara
Universidad Nacional Mayor de San Marcos, Facultad de Medicina. Lima, Perú
2 shared publications
Latest Publications
- Open Access
- 21 October 2026
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
Expanding threat of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Peru: genomic and phenotypic evidence of high-risk clones dissemination
Carbapenemase-producing Enterobacterales represent a growing global threat due to their extensive antimicrobial resistance and rapid dissemination. This study characterized the phenotypic and genomic features of Escherichia coli and Klebsiella pneumoniae isolates collected between 2020 and 2022 from four healthcare institutions in Lima, Peru. A total of 320 non-redundant isolates (61 E. coli and 259 K. pneumoniae ) were analyzed through antimicrobial susceptibility testing, polymerase chain reaction, and whole-genome sequencing. The most frequent carbapenemase gene was bla NDM (69%), followed by bla KPC (16.9%) and bla OXA-48-like (4.6%). Eleven K. pneumoniae isolates co-produced NDM and KPC, and one E. coli isolate co-harbored NDM and OXA-48-like. All isolates were multidrug-resistant, and 5% were resistant to all agents included in the routine panel; however, aztreonam/avibactam and cefiderocol retained complete in vitro activity among tested isolates. Novel β-lactam/β-lactamase inhibitor combinations such as aztreonam/avibactam and cefiderocol showed complete activity against all classes of carbapenemases. Genomic analysis revealed predominant E. coli sequence types ST167 and ST410 and K. pneumoniae lineages ST147, ST15, ST45, and ST273. The bla NDM-5 allele was detected for the first time in Peru, mostly in E. coli ST167 , and was carried on multireplicon IncF-type plasmids. In K. pneumoniae , ST147 was identified as a dominant clone associated with bla NDM-1 , indicating sustained local dissemination of high-risk clonal groups. The coexistence of multiple carbapenemases and plasmid backbones highlights the ongoing evolution of resistance mechanisms. This work provides the first integrative genomic overview of carbapenemase-producing E. coli and K. pneumoniae in Peru and underscores the need for continuous genomic surveillance and antimicrobial stewardship to mitigate their clinical and epidemiological impact.
- 21 October 2026
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
Open AccessExpanding threat of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Peru: genomic and phenotypic evidence of high-risk clones dissemination
Carbapenemase-producing Enterobacterales represent a growing global threat due to their extensive antimicrobial resistance and rapid dissemination. This study characterized the phenotypic and genomic features of Escherichia coli and Klebsiella pneumoniae isolates collected between 2020 and 2022 from four healthcare institutions in Lima, Peru. A total of 320 non-redundant isolates (61 E. coli and 259 K. pneumoniae ) were analyzed through antimicrobial susceptibility testing, polymerase chain reaction, and whole-genome sequencing. The most frequent carbapenemase gene was bla NDM (69%), followed by bla KPC (16.9%) and bla OXA-48-like (4.6%). Eleven K. pneumoniae isolates co-produced NDM and KPC, and one E. coli isolate co-harbored NDM and OXA-48-like. All isolates were multidrug-resistant, and 5% were resistant to all agents included in the routine panel; however, aztreonam/avibactam and cefiderocol retained complete in vitro activity among tested isolates. Novel β-lactam/β-lactamase inhibitor combinations such as aztreonam/avibactam and cefiderocol showed complete activity against all classes of carbapenemases. Genomic analysis revealed predominant E. coli sequence types ST167 and ST410 and K. pneumoniae lineages ST147, ST15, ST45, and ST273. The bla NDM-5 allele was detected for the first time in Peru, mostly in E. coli ST167 , and was carried on multireplicon IncF-type plasmids. In K. pneumoniae , ST147 was identified as a dominant clone associated with bla NDM-1 , indicating sustained local dissemination of high-risk clonal groups. The coexistence of multiple carbapenemases and plasmid backbones highlights the ongoing evolution of resistance mechanisms. This work provides the first integrative genomic overview of carbapenemase-producing E. coli and K. pneumoniae in Peru and underscores the need for continuous genomic surveillance and antimicrobial stewardship to mitigate their clinical and epidemiological impact.
- Open Access
- 13 October 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (10) , e0360681
Antimicrobial resistance and molecular characterization of blaCTX-M-producing Escherichia coli isolated from broiler chickens in Peru
The misuse and overuse of antimicrobials in humans and animals contribute to the selection and dissemination of antimicrobial-resistant (AMR) bacteria. In animal production systems, antimicrobial use is a key driver of the emergence and spread of antimicrobial-resistant bacteria across humans, animals, and the environment within a One Health framework. A total of 300 cloacal swabs were collected from apparently healthy broiler chickens at two poultry collection centers in Lima, Peru. ESBL-producing Escherichia coli were isolated on CHROMagar™ ESBL and identified by conventional biochemical tests. Antimicrobial susceptibility testing was performed using the disk diffusion method according to CLSI guidelines, and ESBL production was phenotypically confirmed. CTX-M groups were detected by qPCR, and whole-genome sequencing (WGS) was performed on selected isolates. Seventy-nine ESBL-producing E. coli isolates were recovered (26.3%; 95% CI: 21.4–31.6). All isolates exhibited multidrug-resistant phenotypes. CTX-M group 1 was detected in 87.3% of isolates and group 9 in 12.7%. WGS analysis identified bla CTX-M-55 , bla CTX-M-65 , and bla CTX-M-3 distributed across multiple sequence types. Phylogenetic analysis revealed the presence of both closely related clonal clusters and genetically diverse isolates. These findings suggest that poultry production systems may serve as potential reservoirs of multidrug-resistant ESBL-producing E. coli in Peru. Given the study design and limited genomic sampling, the results should be interpreted as preliminary and highlight the need for expanded surveillance within a One Health framework.
- 13 October 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (10) , e0360681
Open AccessAntimicrobial resistance and molecular characterization of blaCTX-M-producing Escherichia coli isolated from broiler chickens in Peru
The misuse and overuse of antimicrobials in humans and animals contribute to the selection and dissemination of antimicrobial-resistant (AMR) bacteria. In animal production systems, antimicrobial use is a key driver of the emergence and spread of antimicrobial-resistant bacteria across humans, animals, and the environment within a One Health framework. A total of 300 cloacal swabs were collected from apparently healthy broiler chickens at two poultry collection centers in Lima, Peru. ESBL-producing Escherichia coli were isolated on CHROMagar™ ESBL and identified by conventional biochemical tests. Antimicrobial susceptibility testing was performed using the disk diffusion method according to CLSI guidelines, and ESBL production was phenotypically confirmed. CTX-M groups were detected by qPCR, and whole-genome sequencing (WGS) was performed on selected isolates. Seventy-nine ESBL-producing E. coli isolates were recovered (26.3%; 95% CI: 21.4–31.6). All isolates exhibited multidrug-resistant phenotypes. CTX-M group 1 was detected in 87.3% of isolates and group 9 in 12.7%. WGS analysis identified bla CTX-M-55 , bla CTX-M-65 , and bla CTX-M-3 distributed across multiple sequence types. Phylogenetic analysis revealed the presence of both closely related clonal clusters and genetically diverse isolates. These findings suggest that poultry production systems may serve as potential reservoirs of multidrug-resistant ESBL-producing E. coli in Peru. Given the study design and limited genomic sampling, the results should be interpreted as preliminary and highlight the need for expanded surveillance within a One Health framework.
- Open Access
- 22 June 2026
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- p. 238-43
Enterobacterales multirresistentes portadores del gen acc(6’)-Ian
This study describes carbapenemase-producing enterobacterales isolates obtained from urine samplescollected at a private laboratory in Lima, Peru. Eighty-four carbapenem-resistant strains of Klebsiella pneumoniae and Escherichia coli were analyzed, among which 13 carried the aac(6’)-Ian gene. These isolates showed resistance to amikacin and other aminoglycosides. Furthermore, all isolates carried the blaNDM, blaPER-2, and qnrVC1 genes, associated with IncC2-type plasmids, suggesting a genetic environment with high horizontal transfer potential. Through conjugation assays, we confirmed plasmid transfer to recipient strains, and through genomic analyses, we verified the co-occurrence of resistance genes and mobile genetic elements, highlighting the role of plasmids in the dissemination of these determinants in clinical settings. These findings highlight the need to implement surveillance measures to reduce the risk of infections by multidrug-resistant bacteria in the hospital setting.
- 22 June 2026
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- p. 238-43
Open AccessEnterobacterales multirresistentes portadores del gen acc(6’)-Ian
This study describes carbapenemase-producing enterobacterales isolates obtained from urine samplescollected at a private laboratory in Lima, Peru. Eighty-four carbapenem-resistant strains of Klebsiella pneumoniae and Escherichia coli were analyzed, among which 13 carried the aac(6’)-Ian gene. These isolates showed resistance to amikacin and other aminoglycosides. Furthermore, all isolates carried the blaNDM, blaPER-2, and qnrVC1 genes, associated with IncC2-type plasmids, suggesting a genetic environment with high horizontal transfer potential. Through conjugation assays, we confirmed plasmid transfer to recipient strains, and through genomic analyses, we verified the co-occurrence of resistance genes and mobile genetic elements, highlighting the role of plasmids in the dissemination of these determinants in clinical settings. These findings highlight the need to implement surveillance measures to reduce the risk of infections by multidrug-resistant bacteria in the hospital setting.
- Open Access
Expanding Threat of Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae in Peru: Genomic and Phenotypic Evidence of High-Risk Clones Dissemination
Carbapenemase-producing Enterobacterales represent a growing global threat due to their extensive antimicrobial resistance and rapid dissemination. This study characterized the phenotypic and genomic features of Escherichia coli and Klebsiella pneumoniae isolates collected between 2020 and 2022 from four healthcare institutions in Lima, Peru. A total of 320 non-redundant isolates (61 E. coli and 259 K. pneumoniae ) were analyzed through antimicrobial susceptibility testing, polymerase chain reaction, and whole-genome sequencing. The most frequent carbapenemase gene was bla NDM (69%), followed by bla KPC (16.9%) and bla OXA-48-like (4.6%). Eleven K. pneumoniae isolates co-produced NDM and KPC, and one E. coli isolate co-harbored NDM and OXA-48-like. All isolates were multidrug resistant, and 5% were pandrug resistant. Novel β-lactam/β-lactamase inhibitor combinations such as aztreonam/avibactam and cefiderocol showed complete activity against all classes of carbapenemases. Genomic analysis revealed predominant E. coli sequence types ST167 and ST410 and K. pneumoniae lineages ST147, ST15, ST45, and ST273. The bla NDM-5 allele was detected for the first time in Peru, mostly in E. coli ST167 , carried on multireplicon IncF-type plasmids. In K. pneumoniae , ST147 was identified as a dominant clone associated with bla NDM-1 , indicating sustained local dissemination of high-risk clonal groups. The coexistence of multiple carbapenemases and plasmid backbones highlights the ongoing evolution of resistance mechanisms. These findings provide actionable evidence to guide treatment strategies in settings with high prevalence of metallo-β-lactamases and underscores the need for continuous genomic surveillance and antimicrobial stewardship to mitigate their clinical and epidemiological impact.
Open AccessExpanding Threat of Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae in Peru: Genomic and Phenotypic Evidence of High-Risk Clones Dissemination
Carbapenemase-producing Enterobacterales represent a growing global threat due to their extensive antimicrobial resistance and rapid dissemination. This study characterized the phenotypic and genomic features of Escherichia coli and Klebsiella pneumoniae isolates collected between 2020 and 2022 from four healthcare institutions in Lima, Peru. A total of 320 non-redundant isolates (61 E. coli and 259 K. pneumoniae ) were analyzed through antimicrobial susceptibility testing, polymerase chain reaction, and whole-genome sequencing. The most frequent carbapenemase gene was bla NDM (69%), followed by bla KPC (16.9%) and bla OXA-48-like (4.6%). Eleven K. pneumoniae isolates co-produced NDM and KPC, and one E. coli isolate co-harbored NDM and OXA-48-like. All isolates were multidrug resistant, and 5% were pandrug resistant. Novel β-lactam/β-lactamase inhibitor combinations such as aztreonam/avibactam and cefiderocol showed complete activity against all classes of carbapenemases. Genomic analysis revealed predominant E. coli sequence types ST167 and ST410 and K. pneumoniae lineages ST147, ST15, ST45, and ST273. The bla NDM-5 allele was detected for the first time in Peru, mostly in E. coli ST167 , carried on multireplicon IncF-type plasmids. In K. pneumoniae , ST147 was identified as a dominant clone associated with bla NDM-1 , indicating sustained local dissemination of high-risk clonal groups. The coexistence of multiple carbapenemases and plasmid backbones highlights the ongoing evolution of resistance mechanisms. These findings provide actionable evidence to guide treatment strategies in settings with high prevalence of metallo-β-lactamases and underscores the need for continuous genomic surveillance and antimicrobial stewardship to mitigate their clinical and epidemiological impact.
- Open Access
- 30 October 2025
- Published by Universidad Nacional Mayor de San Marcos, Vicerectorado de Investigacion in Anales de la Facultad de Medicina
- Vol. 86 (4) , 452-456
Caracterización fenotípica y genotípica de factores de virulencia de cepas de Escherichia coli uropatógena productora de carbapenemasa
Introduction. Uropathogenic Escherichia coli (UPEC) is the leading cause of urinary tract infections (UTIs). Its carbapenem-resistant form (UPEC-rC) harbors specific virulence factors that further limit therapeutic options. Objective. Identify virulence factors in UPEC-rC isolates recovered from urine samples of patients with UTIs in Lima, Peru. Methods. We conducted a descriptive observational study including 58 UPEC-rC isolates. Virulence factors were analyzed in the laboratory: phenotypically (hemolysin on blood agar, P fimbriae by erythrocyte hemagglutination and biofilms production using the microtiter plate method) and genotypically (α-hly, papGII, aer, cnf1, sfa/focDE) by PCR. Results. 28 out of 58 isolates exhibited at least one virulence factor. Genotypically, aer gene was the most frequent (34,5%), while phenotypically, biofilm formation predominated (17,2%). Conclusion. The frequency of aer gen and biofilm production suggests a possible relationship between carbapenem resistance and the attenuation of pathogenic mechanisms.
- 30 October 2025
- Published by Universidad Nacional Mayor de San Marcos, Vicerectorado de Investigacion in Anales de la Facultad de Medicina
- Vol. 86 (4) , 452-456
Open AccessCaracterización fenotípica y genotípica de factores de virulencia de cepas de Escherichia coli uropatógena productora de carbapenemasa
Introduction. Uropathogenic Escherichia coli (UPEC) is the leading cause of urinary tract infections (UTIs). Its carbapenem-resistant form (UPEC-rC) harbors specific virulence factors that further limit therapeutic options. Objective. Identify virulence factors in UPEC-rC isolates recovered from urine samples of patients with UTIs in Lima, Peru. Methods. We conducted a descriptive observational study including 58 UPEC-rC isolates. Virulence factors were analyzed in the laboratory: phenotypically (hemolysin on blood agar, P fimbriae by erythrocyte hemagglutination and biofilms production using the microtiter plate method) and genotypically (α-hly, papGII, aer, cnf1, sfa/focDE) by PCR. Results. 28 out of 58 isolates exhibited at least one virulence factor. Genotypically, aer gene was the most frequent (34,5%), while phenotypically, biofilm formation predominated (17,2%). Conclusion. The frequency of aer gen and biofilm production suggests a possible relationship between carbapenem resistance and the attenuation of pathogenic mechanisms.
- Open Access
- 30 September 2025
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 42 (3) , 307-11
Resistencia a colistina y fosfomicina en aislamientos de Escherichia coli productora de betalactamasas de espectro extendido provenientes de pollos de consumo humano
El objetivo del estudio fue determinar la presencia de resistencia a colistina y fosfomicina en aislamientos de Escherichia coli productoras de betalactamasas de espectro extendido (Ec-BLEE) provenientes de pollos de consumo humano. Realizamos un estudio descriptivo transversal y analizamos 79 aislamientos de Ec-BLEE, provenientes de un estudio previo de 300 muestras de hisopado cloacal de pollo. Los aislamientos fueron procesados en el laboratorio de la Facultad de Medicina de la Universidad de Piura. La sensibilidad a colistina se determinó con el medio de detección Colistin-AgarSpot y a fosfomicina mediante antibiograma según los lineamientos de la guía CLSI. Buscamos los genes mcr-1 y fosA3 a través de PCR. Encontramos resistencia a colistina en el 17,7% y a fosfomicina en el 77% de las muestras. El gen mcr-1 no estuvo presente en los aislamientos resistentes a colistina y fosA3 estuvo presente en 100% de los aislamientos resistentes afosfomicina.
- 30 September 2025
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 42 (3) , 307-11
Open AccessResistencia a colistina y fosfomicina en aislamientos de Escherichia coli productora de betalactamasas de espectro extendido provenientes de pollos de consumo humano
El objetivo del estudio fue determinar la presencia de resistencia a colistina y fosfomicina en aislamientos de Escherichia coli productoras de betalactamasas de espectro extendido (Ec-BLEE) provenientes de pollos de consumo humano. Realizamos un estudio descriptivo transversal y analizamos 79 aislamientos de Ec-BLEE, provenientes de un estudio previo de 300 muestras de hisopado cloacal de pollo. Los aislamientos fueron procesados en el laboratorio de la Facultad de Medicina de la Universidad de Piura. La sensibilidad a colistina se determinó con el medio de detección Colistin-AgarSpot y a fosfomicina mediante antibiograma según los lineamientos de la guía CLSI. Buscamos los genes mcr-1 y fosA3 a través de PCR. Encontramos resistencia a colistina en el 17,7% y a fosfomicina en el 77% de las muestras. El gen mcr-1 no estuvo presente en los aislamientos resistentes a colistina y fosA3 estuvo presente en 100% de los aislamientos resistentes afosfomicina.
- Open Access
- 22 January 2025
- Published by Elsevier in Revista Argentina de Microbiologia
- Vol. 57 (1) , 3-7
First report of KPC-35-producing Klebsiella pneumoniae ST258 isolated in Peru
- 22 January 2025
- Published by Elsevier in Revista Argentina de Microbiologia
- Vol. 57 (1) , 3-7
Open AccessFirst report of KPC-35-producing Klebsiella pneumoniae ST258 isolated in Peru
- Open Access
- 19 December 2022
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 39 (4) , 452-62
Identificación de enterobacterias multirresistentes a antibióticos en muestras de heces de lactantes residentes en Talara, Piura, Perú
La colonización fecal en lactantes por bacterias resistentes a los antimicrobianos es un potencial riesgo para futuras terapias antibióticas. Nuestro objetivo fue determinar la frecuencia y características sociodemográficas de lactantes portadores fecales de enterobacterias resistentes a ciprofloxacina (PFRC) y sus genes de resistencia asociados. Analizamos muestras fecales de 41 niños lactantes residentes en el distrito de Talara-Piura, Perú, en 2019. Evaluamos la presencia de 3 genes de resistencia a quinolonas: aac(6’)-Ib-cr, qnrB y oqxA y 2 de betalactamasas: blaCTX-M, blaPER-2.El 68% de lactantes fueron PFRC, Escherichia coli (83,3%) fue el más frecuente. El análisis genotípico detectó: oqxA (41,1%), qnrB (26,7%) y aac(6’)-Ib-cr (20%) y al gen blaCTX-M en el 93,3% de los aislados con betalactamasas. La elevada frecuencia de PFRC nos alertan sobre el potencial riesgo en la pérdida de utilidad de esta familia antibiótica en el área de estudio.
- 19 December 2022
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 39 (4) , 452-62
Open AccessIdentificación de enterobacterias multirresistentes a antibióticos en muestras de heces de lactantes residentes en Talara, Piura, Perú
La colonización fecal en lactantes por bacterias resistentes a los antimicrobianos es un potencial riesgo para futuras terapias antibióticas. Nuestro objetivo fue determinar la frecuencia y características sociodemográficas de lactantes portadores fecales de enterobacterias resistentes a ciprofloxacina (PFRC) y sus genes de resistencia asociados. Analizamos muestras fecales de 41 niños lactantes residentes en el distrito de Talara-Piura, Perú, en 2019. Evaluamos la presencia de 3 genes de resistencia a quinolonas: aac(6’)-Ib-cr, qnrB y oqxA y 2 de betalactamasas: blaCTX-M, blaPER-2.El 68% de lactantes fueron PFRC, Escherichia coli (83,3%) fue el más frecuente. El análisis genotípico detectó: oqxA (41,1%), qnrB (26,7%) y aac(6’)-Ib-cr (20%) y al gen blaCTX-M en el 93,3% de los aislados con betalactamasas. La elevada frecuencia de PFRC nos alertan sobre el potencial riesgo en la pérdida de utilidad de esta familia antibiótica en el área de estudio.
- Open Access
- 19 January 2022
- Published by Universidad Peruana Cayetano Heredia in Revista Médica Herediana
- Vol. 32 (4) , 270-271
Vancomycin-resistant in clinical isolates of Enterococcus
- 19 January 2022
- Published by Universidad Peruana Cayetano Heredia in Revista Médica Herediana
- Vol. 32 (4) , 270-271
Open AccessVancomycin-resistant in clinical isolates of Enterococcus
- Open Access
- 21 August 2020
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 37 (4) , 711-5
Enterobacterales productores de betalactamasa de espectro extendido portadores del gen mcr-1 en Lima, Perú
Se analizó la presencia del gen mcr-1 en 165 enterobacterales productores de betalactamasas de espectro extendido (EP-BLEE) recuperados en 2017 de sangre (40), orina (57), secreciones respiratorias bajas (12) e hisopados rectales (56) de pacientes hospitalizados en el Instituto Nacional de Enfermedades Neoplásicas (Perú). La identificación y la susceptibilidad antimicrobiana se determinaron por el sistema automatizado Phoenix M50; la resistencia a colistina por Colistin Agar-Spot (CAS); la detección de mrc-1 por el método fenotípico de predifusión de colistina e inhibición con EDTA (CPD-E) y por reacción en cadena de la polimerasa (PCR, por sus siglas en inglés). De los 165 EP-BLEE 25 fueron positivos para mcr-1 por el método CPD-E y se confirmó por PCR. Por el método CAS, 20/165 fueron resistentes a colistina. Además, mostraron resistencia a las fluoroquinolonas y a la gentamicina, y permanecieron sensibles a la amikacina; dos aislamientos presentaron metalocarbapenemasas. La obtención de datos sobre la resistencia a antimicrobianos considerados de última línea (colistina) es crucial para establecer medidas para su control.
- 21 August 2020
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 37 (4) , 711-5
Open AccessEnterobacterales productores de betalactamasa de espectro extendido portadores del gen mcr-1 en Lima, Perú
Se analizó la presencia del gen mcr-1 en 165 enterobacterales productores de betalactamasas de espectro extendido (EP-BLEE) recuperados en 2017 de sangre (40), orina (57), secreciones respiratorias bajas (12) e hisopados rectales (56) de pacientes hospitalizados en el Instituto Nacional de Enfermedades Neoplásicas (Perú). La identificación y la susceptibilidad antimicrobiana se determinaron por el sistema automatizado Phoenix M50; la resistencia a colistina por Colistin Agar-Spot (CAS); la detección de mrc-1 por el método fenotípico de predifusión de colistina e inhibición con EDTA (CPD-E) y por reacción en cadena de la polimerasa (PCR, por sus siglas en inglés). De los 165 EP-BLEE 25 fueron positivos para mcr-1 por el método CPD-E y se confirmó por PCR. Por el método CAS, 20/165 fueron resistentes a colistina. Además, mostraron resistencia a las fluoroquinolonas y a la gentamicina, y permanecieron sensibles a la amikacina; dos aislamientos presentaron metalocarbapenemasas. La obtención de datos sobre la resistencia a antimicrobianos considerados de última línea (colistina) es crucial para establecer medidas para su control.